23 results
ARS
2024 FY
CCCC
C4 Therapeutics Inc
30 Apr 24
Annual report to shareholders
8:52am
, these laws include, without limitation, state and federal anti-kickback, false claims, physician transparency and patient data privacy and security … things, bring more transparency to product pricing, review the relationship between pricing and manufacturer patient programs and reform government
ARS
cxjd0pesmhcqsja7ue
28 Apr 23
Annual report to shareholders
7:03am
424B4
vwjgichniv2wx6bey47
21 Jun 21
Prospectus supplement with pricing info
8:08am
DRS
t04t1ihjds 7pr
19 May 21
Draft registration statement
12:00am
10-K
3ldhqa
11 Mar 21
Annual report
4:19pm
10-Q
z11io40
12 Nov 20
Quarterly report
4:28pm
424B4
jsk8t8smv jw
2 Oct 20
Prospectus supplement with pricing info
5:10pm